Table 4 Summary of MI studies.

From: Orally derived mesenchymal stem cells in the treatment of vascular diseases: a systematic review and meta-analysis

Animals

Injury

OMSCs

Administration

Dose

Outcomes

Improved functional outcomes (compared to control group)

References

Rats

Permanent ligation of the left descending coronary artery

hDPSCs

Intramyocardial transplantation

1.5*106 cells

1. Improved functional outcomes (1/1);

2. Cells not differentiated into cardiac or smooth muscle cells;

3. Increased vascular density;

4. Reduced infarcted area

Echocardiographic test (measured cardiac function)

50

Mice

Left anterior descending artery (LAD) was ligated for 30 min, then loosened for reperfusion

SHED-CM

Infused systemically via the jugular vein

500 µl CM

1. Reduced infarct area;

2. Suppressed apoptosis;

3. Suppressed inflammatory responses

 

25

Rabbits

Permanent left circumflex coronary artery was ligated

SHED

Intravenously through rabbit marginal ear vein

1*106 cells

1. Reduced infarct area;

2. Increased myocardial cells and neovascularization;

3. Improved functional outcomes (1/3)

Heart rate test (measured cardiac function)

51

Rats

Permanent ligation of the left anterior descending (LAD) coronary artery

hDPSCs-extracellular vesicles (EVs)

Intramyocardial injection

2.5*109 particles/ mL

1. Reduced infarct size;

2. Decreased the expression of M1 markers in the infarct area;

3. Reduced the infiltrating M1 macrophages in the infarcted area

 

52

  1. CM: conditioned medium; extracellular vesicles: EVs; OMSCs: orally derived mesenchymal stem cells; hDPSCs: human dental pulp stem cells; MI: myocardial ischemia; SHED: stem cells from deciduous teeth.